Philosophical transactions of the Royal Society of London. Series B, Biological sciences, ISSN 0962-8436, 09/2013, Volume 368, Issue 1626, pp. 20120507 - 20120507
The development of the emerging field of 'paleovirology' allows biologists to reconstruct the evolutionary history of fossil endogenous retroviral sequences...
Envelope protein | Cell-cell fusion | Endogenous retrovirus | Placenta | Syncytin | EUKARYOTIC GENOMES | syncytin | envelope protein | HERV-W | endogenous retrovirus | cell-cell fusion | TRANSPOSABLE ELEMENTS | HUMAN ENDOGENOUS RETROVIRUS | EXTRAVILLOUS TROPHOBLAST | EVOLUTION | IN-VIVO | BIOLOGY | placenta | GLYCOPROTEIN | CODING ENVELOPE GENES | CELL-FUSION | Endogenous Retroviruses - physiology | Humans | Pregnancy Proteins - genetics | Endogenous Retroviruses - genetics | Placentation - physiology | Biological Evolution | Pregnancy | Animals | Genes, env | Gene Products, env - genetics | Gene Products, env - physiology | Pregnancy Proteins - physiology | Female | Mice | Genome | Placentation - genetics | cell–cell fusion | 200 | Review | 197
Envelope protein | Cell-cell fusion | Endogenous retrovirus | Placenta | Syncytin | EUKARYOTIC GENOMES | syncytin | envelope protein | HERV-W | endogenous retrovirus | cell-cell fusion | TRANSPOSABLE ELEMENTS | HUMAN ENDOGENOUS RETROVIRUS | EXTRAVILLOUS TROPHOBLAST | EVOLUTION | IN-VIVO | BIOLOGY | placenta | GLYCOPROTEIN | CODING ENVELOPE GENES | CELL-FUSION | Endogenous Retroviruses - physiology | Humans | Pregnancy Proteins - genetics | Endogenous Retroviruses - genetics | Placentation - physiology | Biological Evolution | Pregnancy | Animals | Genes, env | Gene Products, env - genetics | Gene Products, env - physiology | Pregnancy Proteins - physiology | Female | Mice | Genome | Placentation - genetics | cell–cell fusion | 200 | Review | 197
Journal Article
Nature Structural and Molecular Biology, ISSN 1545-9993, 07/2015, Volume 22, Issue 7, pp. 522 - 531
As the sole viral antigen on the HIV-1-virion surface, trimeric Env is a focus of vaccine efforts. Here we present the structure of the ligand-free HIV-1-Env...
PROTEIN | BROAD NEUTRALIZATION | NEUTRALIZING ANTIBODY | BIOCHEMISTRY & MOLECULAR BIOLOGY | HUMAN MONOCLONAL-ANTIBODY | ENVELOPE GLYCOPROTEIN COMPLEX | FUSION GLYCOPROTEIN | GP120 | CELL BIOLOGY | BIOPHYSICS | IMMUNODEFICIENCY-VIRUS TYPE-1 | BINDING-SITE | EPITOPES | CD4 Antigens - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | Protein Multimerization | Models, Molecular | Crystallography, X-Ray | Virus Internalization | Epitopes - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV-1 - physiology | HIV Antibodies - immunology | HIV-1 - chemistry | HEK293 Cells | Protein Conformation | env Gene Products, Human Immunodeficiency Virus - chemistry | Antigens | Vaccines | Molecular biology | Human immunodeficiency virus--HIV | Crystal structure | X-ray crystallography | Computational biology and bioinformatics | Immunology | BASIC BIOLOGICAL SCIENCES | 60 APPLIED LIFE SCIENCES | Viral membrane fusion
PROTEIN | BROAD NEUTRALIZATION | NEUTRALIZING ANTIBODY | BIOCHEMISTRY & MOLECULAR BIOLOGY | HUMAN MONOCLONAL-ANTIBODY | ENVELOPE GLYCOPROTEIN COMPLEX | FUSION GLYCOPROTEIN | GP120 | CELL BIOLOGY | BIOPHYSICS | IMMUNODEFICIENCY-VIRUS TYPE-1 | BINDING-SITE | EPITOPES | CD4 Antigens - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | Protein Multimerization | Models, Molecular | Crystallography, X-Ray | Virus Internalization | Epitopes - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV-1 - physiology | HIV Antibodies - immunology | HIV-1 - chemistry | HEK293 Cells | Protein Conformation | env Gene Products, Human Immunodeficiency Virus - chemistry | Antigens | Vaccines | Molecular biology | Human immunodeficiency virus--HIV | Crystal structure | X-ray crystallography | Computational biology and bioinformatics | Immunology | BASIC BIOLOGICAL SCIENCES | 60 APPLIED LIFE SCIENCES | Viral membrane fusion
Journal Article
Nature, ISSN 0028-0836, 10/2012, Volume 490, Issue 7420, pp. 417 - 420
The RV144 trial demonstrated 31% vaccine efficacy at preventing human immunodeficiency virus (HIV)-1 infection(1). Antibodies against the HIV-1 envelope...
TRIAL | SUBTYPE-C | THAILAND | PROTECTION | SEQUENCES | MULTIDISCIPLINARY SCIENCES | COMPETING RISKS | INFECTION | AIDSVAX | NEUTRALIZATION | EPITOPES | HIV Infections - prevention & control | Genetic Predisposition to Disease | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Phylogeny | HIV-1 - genetics | Sequence Analysis, DNA | AIDS Vaccines - adverse effects | Randomized Controlled Trials as Topic | HIV Infections - immunology | HIV-1 - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV Antibodies - immunology | Prevention | AIDS vaccines | Research | Health aspects | HIV infection | Confidence intervals | Genotype & phenotype | Immunization | Acquired immune deficiency syndrome--AIDS | Amino acids | Statistical methods | Vaccines | Mutation | Binding sites
TRIAL | SUBTYPE-C | THAILAND | PROTECTION | SEQUENCES | MULTIDISCIPLINARY SCIENCES | COMPETING RISKS | INFECTION | AIDSVAX | NEUTRALIZATION | EPITOPES | HIV Infections - prevention & control | Genetic Predisposition to Disease | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Phylogeny | HIV-1 - genetics | Sequence Analysis, DNA | AIDS Vaccines - adverse effects | Randomized Controlled Trials as Topic | HIV Infections - immunology | HIV-1 - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV Antibodies - immunology | Prevention | AIDS vaccines | Research | Health aspects | HIV infection | Confidence intervals | Genotype & phenotype | Immunization | Acquired immune deficiency syndrome--AIDS | Amino acids | Statistical methods | Vaccines | Mutation | Binding sites
Journal Article
Cell Host & Microbe, ISSN 1931-3128, 06/2018, Volume 23, Issue 6, pp. 699 - 701
No immunogen has been found that elicits a broadly neutralizing antibody (bNAb) response sufficient for development into an HIV vaccine. In this issue of ,...
MICROBIOLOGY | PARASITOLOGY | VIROLOGY | Antibodies, Neutralizing | HIV Infections | HIV-1 - immunology | HIV Antibodies | Humans | HIV Envelope Protein gp120 | AIDS Vaccines | Epitopes | env Gene Products, Human Immunodeficiency Virus | Viral antibodies | Antibodies | Antigens | AIDS vaccines | HIV (Viruses)
MICROBIOLOGY | PARASITOLOGY | VIROLOGY | Antibodies, Neutralizing | HIV Infections | HIV-1 - immunology | HIV Antibodies | Humans | HIV Envelope Protein gp120 | AIDS Vaccines | Epitopes | env Gene Products, Human Immunodeficiency Virus | Viral antibodies | Antibodies | Antigens | AIDS vaccines | HIV (Viruses)
Journal Article
Virology, ISSN 0042-6822, 2016, Volume 496, pp. 194 - 202
Abstract Vpr enhances HIV-1 replication in macrophages and dendritic cells, as well as the human CD4+ CEM.NKR T cell line. Recently, Vpr was reported to...
Infectious Disease | Viral protein | Vpr | Protein degradation | Endoplasmic reticulum-associated protein degradation (ERAD) | Glycoprotein | Human immunodeficiency virus (HIV) | PERMEABILITY TRANSITION PORE | APOPTOSIS | DISULFIDE BONDS | T-CELL LINE | ENVELOPE GLYCOPROTEIN-BIOSYNTHESIS | RESTRICTION | HUMAN-IMMUNODEFICIENCY-VIRUS | REPLICATION | VIROLOGY | MITOCHONDRIAL BENZODIAZEPINE-RECEPTOR | TYPE-1 | Endoplasmic Reticulum-Associated Degradation | Cell Line | HIV Infections - virology | Humans | Endoplasmic Reticulum - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | env Gene Products, Human Immunodeficiency Virus - genetics | Animals | HIV-1 - physiology | Virus Replication | Gene Expression Regulation, Viral | Proteolysis | vpr Gene Products, Human Immunodeficiency Virus - metabolism | HIV Infections - metabolism | Prevention | Dendritic cells | HIV (Viruses) | T cells | Viral proteins | Molecular genetics | Microbiology | Macrophages | protein degradation | Endoplasmic reticulum- associated protein degradation (ERAD)
Infectious Disease | Viral protein | Vpr | Protein degradation | Endoplasmic reticulum-associated protein degradation (ERAD) | Glycoprotein | Human immunodeficiency virus (HIV) | PERMEABILITY TRANSITION PORE | APOPTOSIS | DISULFIDE BONDS | T-CELL LINE | ENVELOPE GLYCOPROTEIN-BIOSYNTHESIS | RESTRICTION | HUMAN-IMMUNODEFICIENCY-VIRUS | REPLICATION | VIROLOGY | MITOCHONDRIAL BENZODIAZEPINE-RECEPTOR | TYPE-1 | Endoplasmic Reticulum-Associated Degradation | Cell Line | HIV Infections - virology | Humans | Endoplasmic Reticulum - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | env Gene Products, Human Immunodeficiency Virus - genetics | Animals | HIV-1 - physiology | Virus Replication | Gene Expression Regulation, Viral | Proteolysis | vpr Gene Products, Human Immunodeficiency Virus - metabolism | HIV Infections - metabolism | Prevention | Dendritic cells | HIV (Viruses) | T cells | Viral proteins | Molecular genetics | Microbiology | Macrophages | protein degradation | Endoplasmic reticulum- associated protein degradation (ERAD)
Journal Article
Journal of Virology, ISSN 0022-538X, 2017, Volume 91, Issue 4
SERINC5 is able to restrict HIV-1 infection by drastically impairing the infectivity of viral particles. Studies have shown that the HIV-1 Nef protein counters...
Human immunodeficiency virus | Env | Nef | SERINC5 | NEUTRALIZING ANTIBODIES | NEF PROTEIN | DOWN-REGULATION | BROAD | CD4 | VIROLOGY | COMPLEX CLASS-I | human immunodeficiency virus | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | HUMAN MONOCLONAL-ANTIBODIES | T-LYMPHOCYTES | env Gene Products, Human Immunodeficiency Virus - immunology | Membrane Glycoproteins - metabolism | Humans | Antibodies, Neutralizing - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | HIV Envelope Protein gp120 - metabolism | Antibodies, Neutralizing - immunology | HIV-1 - physiology | Viral Envelope Proteins - metabolism | Inhibitory Concentration 50 | nef Gene Products, Human Immunodeficiency Virus - metabolism | Membrane Proteins - metabolism | HIV Envelope Protein gp120 - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry | Amino Acid Sequence | Cell Line | Peptide Fragments - metabolism | HIV-1 - drug effects | HIV Infections - virology | Cells, Cultured | Antibodies, Neutralizing - pharmacology | HIV-1 - classification | Host-Pathogen Interactions | Peptide Fragments - chemistry | Membrane Proteins - antagonists & inhibitors | Membrane Proteins - chemistry | HIV Infections - metabolism
Human immunodeficiency virus | Env | Nef | SERINC5 | NEUTRALIZING ANTIBODIES | NEF PROTEIN | DOWN-REGULATION | BROAD | CD4 | VIROLOGY | COMPLEX CLASS-I | human immunodeficiency virus | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | HUMAN MONOCLONAL-ANTIBODIES | T-LYMPHOCYTES | env Gene Products, Human Immunodeficiency Virus - immunology | Membrane Glycoproteins - metabolism | Humans | Antibodies, Neutralizing - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | HIV Envelope Protein gp120 - metabolism | Antibodies, Neutralizing - immunology | HIV-1 - physiology | Viral Envelope Proteins - metabolism | Inhibitory Concentration 50 | nef Gene Products, Human Immunodeficiency Virus - metabolism | Membrane Proteins - metabolism | HIV Envelope Protein gp120 - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry | Amino Acid Sequence | Cell Line | Peptide Fragments - metabolism | HIV-1 - drug effects | HIV Infections - virology | Cells, Cultured | Antibodies, Neutralizing - pharmacology | HIV-1 - classification | Host-Pathogen Interactions | Peptide Fragments - chemistry | Membrane Proteins - antagonists & inhibitors | Membrane Proteins - chemistry | HIV Infections - metabolism
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2012, Volume 109, Issue 19, pp. 7385 - 7390
Endogenous retroviruses (ERVs) differ from typical retroviruses in being inherited through the host germline and therefore are a unique combination of pathogen...
Retrotransposons | Family size | Germ cells | Genomics | Retroviridae | Phylogenetics | Genetic loci | Genomes | Reinfection | env genes | CELLS | VIRUS | PARTICLE | FAMILIES | MULTIDISCIPLINARY SCIENCES | MOUSE | LOGNORMAL-DISTRIBUTION | TRANSPOSABLE ELEMENTS | EVOLUTIONARY DYNAMICS | IDENTIFICATION | EMERGENCE | Mammals - genetics | Mammals - classification | Animals | Mammals - virology | Humans | Genome - genetics | Endogenous Retroviruses - genetics | Genes, Intracisternal A-Particle - genetics | Mutagenesis, Insertional | Phylogeny | Endogenous Retroviruses - classification | Genes, env - genetics | Physiological aspects | Genetic aspects | Retroviruses | Research | Genes | Biological Sciences
Retrotransposons | Family size | Germ cells | Genomics | Retroviridae | Phylogenetics | Genetic loci | Genomes | Reinfection | env genes | CELLS | VIRUS | PARTICLE | FAMILIES | MULTIDISCIPLINARY SCIENCES | MOUSE | LOGNORMAL-DISTRIBUTION | TRANSPOSABLE ELEMENTS | EVOLUTIONARY DYNAMICS | IDENTIFICATION | EMERGENCE | Mammals - genetics | Mammals - classification | Animals | Mammals - virology | Humans | Genome - genetics | Endogenous Retroviruses - genetics | Genes, Intracisternal A-Particle - genetics | Mutagenesis, Insertional | Phylogeny | Endogenous Retroviruses - classification | Genes, env - genetics | Physiological aspects | Genetic aspects | Retroviruses | Research | Genes | Biological Sciences
Journal Article
Structure, ISSN 0969-2126, 07/2014, Volume 22, Issue 7, pp. 974 - 984
The HIV envelope glycoprotein (Env) trimer undergoes receptor-induced conformational changes that drive fusion of the viral and cellular membranes. Env...
ENVELOPE GLYCOPROTEIN TRIMERS | ENTRY INHIBITORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GP41 | HYDROGEN/DEUTERIUM EXCHANGE | MASS-SPECTROMETRY | CELL BIOLOGY | NEUTRALIZING ANTIBODY PG9 | BIOPHYSICS | GP120 INNER DOMAIN | IMMUNODEFICIENCY-VIRUS TYPE-1 | CONFORMATIONAL TRANSITIONS | RECEPTOR-BINDING | Oxalates - chemistry | Humans | Protein Multimerization | HIV Envelope Protein gp41 - metabolism | Piperazines - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | Piperazines - chemistry | HIV Envelope Protein gp41 - chemistry | HIV Envelope Protein gp120 - metabolism | Deuterium Exchange Measurement | HIV-1 - physiology | Piperidines - pharmacology | Protein Binding - drug effects | HEK293 Cells | Protein Structure, Quaternary | HIV Envelope Protein gp120 - chemistry | Oxalates - pharmacology | env Gene Products, Human Immunodeficiency Virus - chemistry | HIV-1 - metabolism | Piperidines - chemistry | HIV-1 - drug effects | Piperidines - metabolism | Solubility | Models, Molecular | Glycosylation | Piperazines - pharmacology | Oxalates - metabolism | CD4 Antigens - chemistry | Mass Spectrometry - methods | CD4 Antigens - metabolism | International relief | AIDS vaccines | HIV (Viruses) | Electron microscopy | Hydrogen | NBD-556 | glycoform | CD4 | oxidative labeling | Env trimers | SOSIP | glycoprotein | gp140 | HD exchange | BMS-806 | deuterium exchange
ENVELOPE GLYCOPROTEIN TRIMERS | ENTRY INHIBITORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GP41 | HYDROGEN/DEUTERIUM EXCHANGE | MASS-SPECTROMETRY | CELL BIOLOGY | NEUTRALIZING ANTIBODY PG9 | BIOPHYSICS | GP120 INNER DOMAIN | IMMUNODEFICIENCY-VIRUS TYPE-1 | CONFORMATIONAL TRANSITIONS | RECEPTOR-BINDING | Oxalates - chemistry | Humans | Protein Multimerization | HIV Envelope Protein gp41 - metabolism | Piperazines - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | Piperazines - chemistry | HIV Envelope Protein gp41 - chemistry | HIV Envelope Protein gp120 - metabolism | Deuterium Exchange Measurement | HIV-1 - physiology | Piperidines - pharmacology | Protein Binding - drug effects | HEK293 Cells | Protein Structure, Quaternary | HIV Envelope Protein gp120 - chemistry | Oxalates - pharmacology | env Gene Products, Human Immunodeficiency Virus - chemistry | HIV-1 - metabolism | Piperidines - chemistry | HIV-1 - drug effects | Piperidines - metabolism | Solubility | Models, Molecular | Glycosylation | Piperazines - pharmacology | Oxalates - metabolism | CD4 Antigens - chemistry | Mass Spectrometry - methods | CD4 Antigens - metabolism | International relief | AIDS vaccines | HIV (Viruses) | Electron microscopy | Hydrogen | NBD-556 | glycoform | CD4 | oxidative labeling | Env trimers | SOSIP | glycoprotein | gp140 | HD exchange | BMS-806 | deuterium exchange
Journal Article
Journal of Virology, ISSN 0022-538X, 06/2011, Volume 85, Issue 12, pp. 5825 - 5839
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
PROTEOLYTIC CLEAVAGE | VIROLOGY | INTRACELLULAR-TRANSPORT | NEUTRALIZING ANTIBODY | SIGNAL SEQUENCE | TYPE-1 ENVELOPE | OLIGOMERIC STRUCTURE | ENVELOPE GLYCOPROTEIN COMPLEX | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | ENDOPROTEOLYTIC CLEAVAGE | HIV Envelope Protein gp120 - genetics | Cell Line | HIV-1 - metabolism | HIV Envelope Protein gp41 - genetics | HIV-1 - pathogenicity | env Gene Products, Human Immunodeficiency Virus - immunology | Virion - pathogenicity | Humans | Endoplasmic Reticulum - metabolism | HIV Envelope Protein gp41 - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | Glycosylation | HIV-1 - genetics | HIV Envelope Protein gp120 - metabolism | Protein Binding | Antibodies, Monoclonal - metabolism | Glycoside Hydrolases - metabolism | Binding Sites | HIV Envelope Protein gp160 - metabolism | env Gene Products, Human Immunodeficiency Virus - chemistry | Peptide Hydrolases - metabolism | Pathogenesis and Immunity
PROTEOLYTIC CLEAVAGE | VIROLOGY | INTRACELLULAR-TRANSPORT | NEUTRALIZING ANTIBODY | SIGNAL SEQUENCE | TYPE-1 ENVELOPE | OLIGOMERIC STRUCTURE | ENVELOPE GLYCOPROTEIN COMPLEX | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | ENDOPROTEOLYTIC CLEAVAGE | HIV Envelope Protein gp120 - genetics | Cell Line | HIV-1 - metabolism | HIV Envelope Protein gp41 - genetics | HIV-1 - pathogenicity | env Gene Products, Human Immunodeficiency Virus - immunology | Virion - pathogenicity | Humans | Endoplasmic Reticulum - metabolism | HIV Envelope Protein gp41 - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | Glycosylation | HIV-1 - genetics | HIV Envelope Protein gp120 - metabolism | Protein Binding | Antibodies, Monoclonal - metabolism | Glycoside Hydrolases - metabolism | Binding Sites | HIV Envelope Protein gp160 - metabolism | env Gene Products, Human Immunodeficiency Virus - chemistry | Peptide Hydrolases - metabolism | Pathogenesis and Immunity
Journal Article
Journal of virology, ISSN 0022-538X, 2015, Volume 89, Issue 6, pp. 3380 - 3395
Recombinant trimeric mimics of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) spike should expose as many epitopes as possible for...
ENVELOPE GLYCOPROTEIN TRIMERS | TYPE-1 ISOLATE | NEUTRALIZING ANTIBODIES | VIROLOGY | PARTIAL DELETION | MONOMERIC GP120 | DISULFIDE BOND | HUMAN-IMMUNODEFICIENCY-VIRUS | MONOCLONAL-ANTIBODIES | DEPENDENT EPITOPE | GP41-GP120 INTERFACE | AIDS Vaccines - isolation & purification | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | Protein Multimerization | AIDS Vaccines - immunology | env Gene Products, Human Immunodeficiency Virus - isolation & purification | Epitopes - genetics | HIV-1 - genetics | AIDS Vaccines - chemistry | HIV-1 - classification | Epitopes - immunology | HIV-1 - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV-1 - chemistry | AIDS Vaccines - genetics | Epitopes - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry
ENVELOPE GLYCOPROTEIN TRIMERS | TYPE-1 ISOLATE | NEUTRALIZING ANTIBODIES | VIROLOGY | PARTIAL DELETION | MONOMERIC GP120 | DISULFIDE BOND | HUMAN-IMMUNODEFICIENCY-VIRUS | MONOCLONAL-ANTIBODIES | DEPENDENT EPITOPE | GP41-GP120 INTERFACE | AIDS Vaccines - isolation & purification | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | Protein Multimerization | AIDS Vaccines - immunology | env Gene Products, Human Immunodeficiency Virus - isolation & purification | Epitopes - genetics | HIV-1 - genetics | AIDS Vaccines - chemistry | HIV-1 - classification | Epitopes - immunology | HIV-1 - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV-1 - chemistry | AIDS Vaccines - genetics | Epitopes - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry
Journal Article
11.
Full Text
GagPol-specific CD4+ T-cells increase the antibody response to Env by intrastructural help
Retrovirology, ISSN 1742-4690, 10/2013, Volume 10, Issue 1, pp. 117 - 117
Background: Immunization of rhesus macaques against Gag of SIV resulted in a more rapid appearance of Env antibodies after infection with SIV or SHIV challenge...
SIV | Env antibody response | HIV VLPs | Gag specific CD4+ T cells | Intrastructural help | HEMAGGLUTININ | RHESUS-MONKEYS | Gag specific CD4+T cells | LENTIVIRAL VECTORS | INTERNAL COMPONENTS | IMMUNIZATION | CHALLENGE | VIROLOGY | SIMIAN IMMUNODEFICIENCY VIRUS | INFECTION | INFLUENZA-VIRUS | EXPRESSION | Gene Products, gag - immunology | Gene Products, env - immunology | SAIDS Vaccines - administration & dosage | Immunization - methods | Coculture Techniques | Vaccines, DNA - immunology | Adoptive Transfer | Vaccines, DNA - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Animals | B-Lymphocytes - immunology | SAIDS Vaccines - immunology | Gene Products, pol - immunology | Vaccines, Virus-Like Particle - immunology | Mice | Simian Immunodeficiency Virus - immunology | Immune response | Viral proteins | Genetic engineering | B cells | HIV (Viruses) | T cells | HIV infection | Biotechnology industry
SIV | Env antibody response | HIV VLPs | Gag specific CD4+ T cells | Intrastructural help | HEMAGGLUTININ | RHESUS-MONKEYS | Gag specific CD4+T cells | LENTIVIRAL VECTORS | INTERNAL COMPONENTS | IMMUNIZATION | CHALLENGE | VIROLOGY | SIMIAN IMMUNODEFICIENCY VIRUS | INFECTION | INFLUENZA-VIRUS | EXPRESSION | Gene Products, gag - immunology | Gene Products, env - immunology | SAIDS Vaccines - administration & dosage | Immunization - methods | Coculture Techniques | Vaccines, DNA - immunology | Adoptive Transfer | Vaccines, DNA - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Animals | B-Lymphocytes - immunology | SAIDS Vaccines - immunology | Gene Products, pol - immunology | Vaccines, Virus-Like Particle - immunology | Mice | Simian Immunodeficiency Virus - immunology | Immune response | Viral proteins | Genetic engineering | B cells | HIV (Viruses) | T cells | HIV infection | Biotechnology industry
Journal Article